Link to this page
Chemical Entities of Biological Interest Ontology
Last uploaded:
December 1, 2024
Jump to:
Preferred Name | eszopiclone | |
Synonyms |
(S)-Zopiclone (+)-Zopiclone (+)-(5S)-6-(5-Chloropyridin-2-yl)-7-oxo-6,7-dihydro-5H-pyrrolo(3,4-b)pyrazin-5-yl 4-methylpiperazine-1-carboxylate Esopiclone eszopiclone (5S)-6-(5-chloropyridin-2-yl)-7-oxo-6,7-dihydro-5H-pyrrolo[3,4-b]pyrazin-5-yl 4-methylpiperazine-1-carboxylate |
|
Definitions |
The (5S)- (active) enantiomer of zopiclone. Unlike almost all other hypnotic sedatives, which are approved only for the relief of short-term (6-8 weeks) insomnia, eszopiclone is approved by the U.S. Food and Drug Administration for long-term use. |
|
ID |
http://purl.obolibrary.org/obo/CHEBI_53760 |
|
charge |
0
|
|
database_cross_reference |
DrugBank:DB00402 Beilstein:8794636 Wikipedia:Eszopiclone KEGG:D02624 Drug_Central:1068 CAS:138729-47-2
|
|
definition |
The (5S)- (active) enantiomer of zopiclone. Unlike almost all other hypnotic sedatives, which are approved only for the relief of short-term (6-8 weeks) insomnia, eszopiclone is approved by the U.S. Food and Drug Administration for long-term use.
|
|
formula |
C17H17ClN6O3
|
|
has role | ||
has_exact_synonym |
(5S)-6-(5-chloropyridin-2-yl)-7-oxo-6,7-dihydro-5H-pyrrolo[3,4-b]pyrazin-5-yl 4-methylpiperazine-1-carboxylate
|
|
has_obo_namespace |
chebi_ontology
|
|
has_related_synonym |
(S)-Zopiclone (+)-Zopiclone (+)-(5S)-6-(5-Chloropyridin-2-yl)-7-oxo-6,7-dihydro-5H-pyrrolo(3,4-b)pyrazin-5-yl 4-methylpiperazine-1-carboxylate Esopiclone eszopiclone
|
|
id |
CHEBI:53760
|
|
in_subset | ||
inchi |
InChI=1S/C17H17ClN6O3/c1-22-6-8-23(9-7-22)17(26)27-16-14-13(19-4-5-20-14)15(25)24(16)12-3-2-11(18)10-21-12/h2-5,10,16H,6-9H2,1H3/t16-/m0/s1
|
|
inchikey |
GBBSUAFBMRNDJC-INIZCTEOSA-N
|
|
is enantiomer of | ||
label |
eszopiclone
|
|
mass |
388.80800
|
|
monoisotopicmass |
388.10507
|
|
notation |
CHEBI:53760
|
|
prefLabel |
eszopiclone
|
|
smiles |
CN1CCN(CC1)C(=O)O[C@@H]1N(C(=O)c2nccnc12)c1ccc(Cl)cn1
|
|
treeView | ||
subClassOf |
Add comment
Delete | Subject | Author | Type | Created |
---|---|---|---|---|
No notes to display |
Create mapping